<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In the formalin test, EOPPgfl (20, 30, and 60 mg/kg) significantly reduced the time the animal spent licking its paw in both phases of the test (
 <xref ref-type="fig" rid="f02" class="xref">Figure 2A and B</xref>) compared to the control (1st phase 74.85±2.26 s (n=8) and the 2nd phase 135±7.61 s (n=8)). At the dose of 20 mg/kg, for the first (
 <xref ref-type="fig" rid="f02" class="xref">Figure 2A</xref>) and second phase (
 <xref ref-type="fig" rid="f02" class="xref">Figure 2B</xref>), the time of licking was reduced to 46.1 and 82.6 s, respectively, at the dose of 30 mg/kg, to 59.7 and 72.6 s (n=7), and at the dose of 60 mg/kg, to 44.3 and 74.1 s (n=7). This effect was not altered (P&gt;0.05, ANOVA) by subcutaneous injection of naloxone, an antagonist of opioid receptor (
 <xref ref-type="fig" rid="f02" class="xref">Figure 2A and B</xref>).
</p>
